CLYNAV injektioneste, liuos Finlandia - finlandese - Fimea (Suomen lääkevirasto)

clynav injektioneste, liuos

novartis animal health uk ltd - puhdistettu plasmidi-dna - injektioneste, liuos

Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Unione Europea - finlandese - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - influenssa virus pinta-antigeenejä (haemagglutinin ja neuraminidaasin) kanta a, vietnam, 1194, 2004 (h5n1) - influenza, human; immunization; disease outbreaks - rokotteet - aktiivinen immunisaatio influenssa a -viruksen h5n1-alatyypin suhteen. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

ZOBUXA VET 15 mg tabletti Finlandia - finlandese - Fimea (Suomen lääkevirasto)

zobuxa vet 15 mg tabletti

novartis healthcare a/s animal health - enrofloxacinum - tabletti - 15 mg - enrofloksasiini

ZOBUXA VET 50 mg tabletti Finlandia - finlandese - Fimea (Suomen lääkevirasto)

zobuxa vet 50 mg tabletti

novartis healthcare a/s animal health - enrofloxacinum - tabletti - 50 mg - enrofloksasiini

ZOBUXA VET 100 mg tabletti Finlandia - finlandese - Fimea (Suomen lääkevirasto)

zobuxa vet 100 mg tabletti

novartis healthcare a/s animal health - enrofloxacinum - tabletti - 100 mg - enrofloksasiini

ZOBUXA VET 150 mg tabletti Finlandia - finlandese - Fimea (Suomen lääkevirasto)

zobuxa vet 150 mg tabletti

novartis healthcare a/s animal health - enrofloxacinum - tabletti - 150 mg - enrofloksasiini

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Unione Europea - finlandese - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptiini, metformiinihydrokloridia - diabetes mellitus, tyyppi 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 käytettävissä olevista tiedoista eri yhdistelmistä).

Tekturna Unione Europea - finlandese - EMA (European Medicines Agency)

tekturna

novartis europharm ltd. - aliskireeni - verenpainetauti - reniini-angiotensiinijärjestelmään vaikuttavat aineet - essentiaalisen hypertension hoito.

Imprida Unione Europea - finlandese - EMA (European Medicines Agency)

imprida

novartis europharm ltd - valsartan, amlodipine (as amlodipine besilate) - verenpainetauti - reniini-angiotensiinijärjestelmään vaikuttavat aineet - essentiaalisen hypertension hoito. imprida on tarkoitettu potilaille, joiden verenpaine ei laske riittävästi yksinomaan amlodipiinilla tai valsartaanilla.

Enviage Unione Europea - finlandese - EMA (European Medicines Agency)

enviage

novartis europharm ltd. - aliskireeni - verenpainetauti - reniini-angiotensiinijärjestelmään vaikuttavat aineet - essentiaalisen hypertension hoito.